Anti-PLCG1 (Phospho-Tyr771) polyclonal Antibody detects PLCG1 only when phosphorylated at Tyr771. Validated for WB, IHC and ELISA. Reactive for Human, Mouse, Rat. AssayBiotechnology an original antibody manufacturer.
Details
-
Product Name
PLCG1 (Phospho-Tyr771) Antibody
-
Catalog No
A0079
-
Storage/Stability
Stable at -20°C for at least 1 year.
-
Applications
WB, IHC, ELISA
-
Clonality
Polyclonal
-
Host Species
Rabbit
-
Reactivity
Human, Mouse, Rat
-
Application Dilutions
WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:40000
-
Database Links
Gene ID: 5335, Swiss-Prot #: P19174, OMIM #: 172420, Unigene #: Hs.268177
-
Immunogen
The antiserum was produced against synthesized peptide derived from human PLCG1 around the phosphorylation site of Tyr771.
-
Immunogen Range
736-785
-
Modification Sites
H: Y771 M: Y771 R: Y771
-
MW
148 kDa
-
NCBI Gene Symbol
PLCG1
-
Physical Form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
-
Purification
The antibody was purified from rabbit antiserum by affinity-chromatography using phospho peptide. The antibody against non-phospho peptide was removed by chromatography using corresponding non-phospho peptide.
-
Specificity
PLCG1 (Phospho-Tyr771) Antibody detects endogenous levels of PLCG1 only when phosphorylated at Tyr771.
-
Synonyms
1-phosphatidylinositol-4, 5-bisphosphate phosphodiesterase gamma-1, PLC-148, Phosphoinositide phospholipase C-gamma-1, Phospholipase C-II, PLC-II, Phospholipase C-gamma-1, PLC-gamma-1 , PLCG1, PLC1
-
Target Modification
Phospho
Application Images
Western blot analysis of lysates from COS7 cells treated with EGF 200ng/ml 30', using PLCG1 (Phospho-Tyr771) Antibody. The lane on the right is blocked with the phospho peptide.
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using PLCG1 (Phospho-Tyr771) Antibody. The picture on the right is blocked with the phospho peptide.
Western Blot analysis of various cells using Phospho-PLC gamma1 (Y771) Antibody
Immunohistochemical analysis of paraffin-embedded Human breast cancer. Antibody was diluted at 1:100(4°,ON). Negative control (right) obtaned from antibody was pre-absorbed by immunogen peptide.
Immunohistochemical analysis of paraffin-embedded Human breast cancer. Antibody was diluted at 1:100(4°,ON). Negative control (right) obtaned from antibody was pre-absorbed by immunogen peptide.
|
Western blot analysis of lysates from COS7 cells treated with EGF 200ng/ml 30', using PLCG1 (Phospho-Tyr771) Antibody. The lane on the right is blocked with the phospho peptide. |
|
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using PLCG1 (Phospho-Tyr771) Antibody. The picture on the right is blocked with the phospho peptide. |
|
Western Blot analysis of various cells using Phospho-PLC gamma1 (Y771) Antibody |
|
Immunohistochemical analysis of paraffin-embedded Human breast cancer. Antibody was diluted at 1:100(4°,ON). Negative control (right) obtaned from antibody was pre-absorbed by immunogen peptide. |
|
Immunohistochemical analysis of paraffin-embedded Human breast cancer. Antibody was diluted at 1:100(4°,ON). Negative control (right) obtaned from antibody was pre-absorbed by immunogen peptide. |
Follow us on Twitter
Follow us on Linkedin
Like us on Facebook
Subscribe to our Channel